No Data
No Data
No Data
No Data
No Data
Earnings Call Summary | Ionis Pharmaceuticals(IONS.US) Q1 2024 Earnings Conference
The following is a summary of the Ionis Pharmaceuticals, Inc. (IONS) Q1 2024 Earnings Call Transcript:Financial Performance:Ionis Pharmaceuticals reported first-quarter revenues of $119 million, half
moomoo AI21:24 ET · Conference Call
Ionis Pharmaceuticals(IONS.US) Director Sells US$256.28K in Common Stock
$Ionis Pharmaceuticals(IONS.US)$ Director KLEIN JOSEPH III sold 6,000 shares of common stock on May 3, 2024 at an average price of $42.7128 for a total value of $256.28K.Source: Announcement What is s
moomoo News17:40 ET
Ionis Pharmaceuticals Insider Sold Shares Worth $256,277, According to a Recent SEC Filing
Joseph Iii Klein, Director, on May 03, 2024, sold 6,000 shares in Ionis Pharmaceuticals (IONS) for $256,277. Following the Form 4 filing with the SEC, Klein has control over a total of 16,446 shares o
MT Newswires17:02 ET
Ionis Pharmaceuticals | 10-Q: Quarterly report
Futu News16:01 ET · Announcements
Ionis Pharmaceuticals: A Buy Rating Amidst Strong 2024 Outlook and Key Milestone Anticipation
TipRanks15:35 ET
Research Alert: CFRA Retains Buy Opinion On Shares Of Ionis Pharmaceuticals, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target to $49 from $53, bas
MT Newswires12:00 ET
No Data
No Data